We've all heard the adage, "If at first you don't succeed, try, try again," but new research from Carnegie Mellon University and the University of Pittsburgh finds that it isn't all about repetition. Rather, internal states ...
Mar 31, 2021
0
69
Three days after testing positive for COVID-19, "everything tasted like cardboard," recalls 38-year-old Elizabeth Medina, who lost her sense of taste and smell at the start of the pandemic. A year later, she fears she will ...
Mar 28, 2021
0
28
About two decades after first devising a new kind of vaccine, Oregon Health & Science University researchers are unlocking why it stops and ultimately clears the monkey form of HIV, called SIV, in about half of nonhuman primates—and ...
Mar 25, 2021
0
124
COVID-19 disproportionately affects men compared with women, raising the possibility that a hormone like progesterone may improve clinical outcomes for certain hospitalized men with the disease. New research from Cedars-Sinai ...
Mar 18, 2021
0
8
Eli Lilly & Co. presented highly anticipated details from a mid-stage study showing that its experimental drug modestly slowed Alzheimer's disease progression over about 18 months.
Mar 15, 2021
0
3
When we recall a memory, we retrieve specific details about it: where, when, with whom. But we often also experience a vivid feeling of remembering the event, sometimes almost reliving it. Memory researchers call these processes ...
Mar 10, 2021
0
15
People with unhealthy heart structures and poorer functioning hearts have a significantly higher risk of being diagnosed with COVID-19 infection, according to research by Queen Mary University of London, in collaboration ...
Mar 9, 2021
0
8
Randomized clinical trials are the undisputed gold standard for determining whether a treatment protocol is effective for a specific disease or condition.
Mar 3, 2021
0
1
The human gut consists of a complex community of microbes that consume and secrete hundreds of small molecules—a phenomenon called cross-feeding. However, it is challenging to study these processes experimentally. A new ...
Mar 1, 2021
3
62
A recent preclinical study by U.S. Military HIV Research Program (MHRP) researchers showed that an experimental therapy combining a TLR7 agonist and two broadly neutralizing antibodies delayed viral rebound in SHIV-infected ...
Mar 1, 2021
0
28
